Eunhee Kim Selected Research

KR33493

11/2016

Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eunhee Kim Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 06/2003
16	Stroke (Strokes) 01/2022 - 04/2008
11	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2009
7	Infarction (Infarctions) 01/2022 - 01/2007
7	Ischemia 10/2018 - 02/2004
6	Necrosis 01/2020 - 01/2013
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2015
5	Human Influenza (Influenza) 09/2020 - 01/2011
5	Leukemia 09/2016 - 06/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 05/2015
4	Infections 09/2020 - 12/2010
4	Ischemic Stroke 01/2020 - 02/2007
4	Glioma (Gliomas) 01/2020 - 05/2009
4	Hypoxia (Hypoxemia) 10/2017 - 02/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2005
3	Breast Neoplasms (Breast Cancer) 06/2018 - 01/2017
3	Inflammation (Inflammations) 01/2018 - 12/2010
3	Brain Injuries (Brain Injury) 06/2012 - 02/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2010
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 01/2019
2	Retinal Degeneration 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2006
2	Neuroblastoma 09/2019 - 01/2016
2	Cerebral Infarction 10/2018 - 02/2007
2	RNA Virus Infections 01/2018 - 05/2017
2	Adenoma (Adenomas) 12/2017 - 04/2004
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2017 - 01/2017
2	Brain Ischemia (Cerebral Ischemia) 05/2014 - 02/2007
2	Anemia 01/2009 - 02/2007
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2005 - 04/2004
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	COVID-19 11/2021
1	Common Cold 09/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
6	CytokinesIBA 11/2021 - 04/2008
6	Messenger RNA (mRNA)IBA 01/2020 - 04/2004
4	RNA Splicing FactorsIBA 01/2022 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2015
3	LigandsIBA 01/2022 - 02/2007
3	SynucleinsIBA 01/2022 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	Bevacizumab (Avastin)FDA Link 01/2021 - 05/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2018
3	Neuraminidase (Sialidase)IBA 01/2020 - 01/2011
3	Protein Kinases (Protein Kinase)IBA 01/2019 - 10/2017
3	Retinaldehyde (Retinal)IBA 01/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 08/2017 - 01/2017
3	Contrast MediaIBA 06/2016 - 05/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 05/2014
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2014 - 04/2008
2	CorticosteroneIBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 07/2018
2	Interleukin-3 (Interleukin 3)IBA 01/2021 - 06/2013
2	Antiviral Agents (Antivirals)IBA 09/2020 - 05/2017
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 09/2019
2	EnzymesIBA 07/2018 - 01/2017
2	Interferon Type IIBA 01/2018 - 05/2017
2	Biological ProductsIBA 01/2018 - 01/2016
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 05/2014
2	Oxygen (Dioxygen)IBA 10/2017 - 01/2017
2	Lysine (L-Lysine)FDA Link 01/2017 - 04/2016
2	AntioxidantsIBA 08/2016 - 02/2007
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 12/2006
2	Apolipoproteins E (ApoE)IBA 11/2015 - 04/2008
2	CholesterolIBA 11/2015 - 11/2006
2	VemurafenibIBA 10/2015 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 08/2012
2	Oseltamivir (Tamiflu)FDA Link 06/2012 - 01/2011
2	4,4',5'-trimethylazapsoralenIBA 01/2009 - 09/2006
2	Peptides (Polypeptides)IBA 02/2007 - 10/2006
2	Adenosine Diphosphate (ADP)IBA 01/2005 - 10/2003
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2005 - 04/2004
2	BuffersIBA 12/2004 - 02/2004
1	EndoglinIBA 01/2022
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	IronIBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	KM-819IBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	Metyrapone FDA Link 01/2022
1	GlucocorticoidsIBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2022
1	CC ChemokinesIBA 11/2021
1	Syndecan-1 (Syndecan 1)IBA 11/2021
1	Interleukin-10 (Interleukin 10)IBA 11/2021
1	Furocoumarins (Furanocoumarins)IBA 09/2020
1	kumi-kyokatsu-toIBA 09/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2020

Therapy/Procedure

20	Therapeutics 01/2021 - 06/2003
2	Neoadjuvant Therapy 06/2018 - 01/2017
2	Aftercare (After-Treatment) 10/2015 - 03/2010
1	Intraperitoneal Injections 01/2022
1	Radiotherapy 01/2021